Cargando…
A Genome-Scale Metabolic Model for the Human Pathogen Candida Parapsilosis and Early Identification of Putative Novel Antifungal Drug Targets
Candida parapsilosis is an emerging human pathogen whose incidence is rising worldwide, while an increasing number of clinical isolates display resistance to first-line antifungals, demanding alternative therapeutics. Genome-Scale Metabolic Models (GSMMs) have emerged as a powerful in silico tool fo...
Autores principales: | Viana, Romeu, Couceiro, Diogo, Carreiro, Tiago, Dias, Oscar, Rocha, Isabel, Teixeira, Miguel Cacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871546/ https://www.ncbi.nlm.nih.gov/pubmed/35205348 http://dx.doi.org/10.3390/genes13020303 |
Ejemplares similares
-
Genome-Scale Metabolic Model of the Human Pathogen Candida albicans: A Promising Platform for Drug Target Prediction
por: Viana, Romeu, et al.
Publicado: (2020) -
Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019) -
Vaginal Candida parapsilosis: pathogen or bystander?
por: Nyirjesy, Paul, et al.
Publicado: (2005) -
Candida parapsilosis: an emerging fungal pathogen
por: Singh, Rakesh, et al.
Publicado: (2012) -
Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran
por: LOTFALI, Ensieh, et al.
Publicado: (2016)